A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

Norbert Schmitz; Lorenz Truemper; Krimo Bouabdallah; Marita Ziepert; Mathieu Leclerc; Guillaume Cartron; Arnaud Jaccard; Peter Reimer; Eva Wagner; Martin Wilhelm; Laurence Sanhes; Thierry Lamy; Laurence de Leval; Andreas Rosenwald; Muriel Roussel; Frank Kroschinsky; Walter Lindemann; Peter Dreger; Andreas Viardot; Noël Milpied; Christian Gisselbrecht; Gerald Wulf; Emmanuel Gyan; Philippe Gaulard; Jacques Olivier Bay; Bertram Glass; Viola Poeschel; Gandhi Damaj; David Sibon; Alain Delmer; Karin Bilger; Anne Banos; Mathias Haenel; Martin Dreyling; Bernd Metzner; Ulrich Keller; Friederike Braulke; Birte Friedrichs; Maike Nickelsen; Bettina Altmann; Olivier Tournilhac

doi:10.1182/blood.2020008825

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

Norbert Schmitz, Lorenz Truemper, Krimo Bouabdallah, Marita Ziepert, Mathieu Leclerc, Guillaume Cartron, Arnaud Jaccard, Peter Reimer, Eva Wagner, Martin Wilhelm (Co-author), Laurence Sanhes, Thierry Lamy, Laurence de Leval, Andreas Rosenwald, Muriel Roussel, Frank Kroschinsky, Walter Lindemann, Peter Dreger, Andreas Viardot, Noël MilpiedChristian Gisselbrecht, Gerald Wulf, Emmanuel Gyan, Philippe Gaulard, Jacques Olivier Bay, Bertram Glass, Viola Poeschel, Gandhi Damaj, David Sibon, Alain Delmer, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Bernd Metzner, Ulrich Keller, Friederike Braulke, Birte Friedrichs, Maike Nickelsen, Bettina Altmann, Olivier Tournilhac

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Original Article › peer-review

66 Citations (Web of Science)

Original language	English
Pages (from-to)	2646-2656
Journal	BLOOD
Volume	137
Issue number	19
DOIs	https://doi.org/10.1182/blood.2020008825
Publication status	Published - 2021

Keywords

STEM-CELL TRANSPLANTATION
VERSUS-HOST-DISEASE
LYMPHOMA
CRITERIA

Access to Document

10.1182/blood.2020008825

Cite this

Schmitz, N., Truemper, L., Bouabdallah, K., Ziepert, M., Leclerc, M., Cartron, G., Jaccard, A., Reimer, P., Wagner, E., Wilhelm, M., Sanhes, L., Lamy, T., de Leval, L., Rosenwald, A., Roussel, M., Kroschinsky, F., Lindemann, W., Dreger, P., Viardot, A., ... Tournilhac, O. (2021). A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. BLOOD , 137(19), 2646-2656. https://doi.org/10.1182/blood.2020008825

Schmitz, Norbert ; Truemper, Lorenz ; Bouabdallah, Krimo et al. / A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. In: BLOOD 2021 ; Vol. 137, No. 19. pp. 2646-2656.

@article{7a920ae19af44adcbc99c8e239e269c2,

title = "A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.",

keywords = "STEM-CELL TRANSPLANTATION, VERSUS-HOST-DISEASE, LYMPHOMA, CRITERIA",

author = "Norbert Schmitz and Lorenz Truemper and Krimo Bouabdallah and Marita Ziepert and Mathieu Leclerc and Guillaume Cartron and Arnaud Jaccard and Peter Reimer and Eva Wagner and Martin Wilhelm and Laurence Sanhes and Thierry Lamy and {de Leval}, Laurence and Andreas Rosenwald and Muriel Roussel and Frank Kroschinsky and Walter Lindemann and Peter Dreger and Andreas Viardot and No{\"e}l Milpied and Christian Gisselbrecht and Gerald Wulf and Emmanuel Gyan and Philippe Gaulard and Bay, {Jacques Olivier} and Bertram Glass and Viola Poeschel and Gandhi Damaj and David Sibon and Alain Delmer and Karin Bilger and Anne Banos and Mathias Haenel and Martin Dreyling and Bernd Metzner and Ulrich Keller and Friederike Braulke and Birte Friedrichs and Maike Nickelsen and Bettina Altmann and Olivier Tournilhac",

note = "Wilhelm: Medizinische Klinik 5, Klinikum Nuernberg, Paracelsus Medical University, Klinikum Nuernberg, Nuernberg, Germany; ",

year = "2021",

doi = "10.1182/blood.2020008825",

language = "English",

volume = "137",

pages = "2646--2656",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "19",

}

Schmitz, N, Truemper, L, Bouabdallah, K, Ziepert, M, Leclerc, M, Cartron, G, Jaccard, A, Reimer, P, Wagner, E, Wilhelm, M, Sanhes, L, Lamy, T, de Leval, L, Rosenwald, A, Roussel, M, Kroschinsky, F, Lindemann, W, Dreger, P, Viardot, A, Milpied, N, Gisselbrecht, C, Wulf, G, Gyan, E, Gaulard, P, Bay, JO, Glass, B, Poeschel, V, Damaj, G, Sibon, D, Delmer, A, Bilger, K, Banos, A, Haenel, M, Dreyling, M, Metzner, B, Keller, U, Braulke, F, Friedrichs, B, Nickelsen, M, Altmann, B & Tournilhac, O 2021, 'A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.', BLOOD , vol. 137, no. 19, pp. 2646-2656. https://doi.org/10.1182/blood.2020008825

A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. / Schmitz, Norbert; Truemper, Lorenz; Bouabdallah, Krimo et al.
In: BLOOD , Vol. 137, No. 19, 2021, p. 2646-2656.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.

AU - Schmitz, Norbert

AU - Truemper, Lorenz

AU - Bouabdallah, Krimo

AU - Ziepert, Marita

AU - Leclerc, Mathieu

AU - Cartron, Guillaume

AU - Jaccard, Arnaud

AU - Reimer, Peter

AU - Wagner, Eva

AU - Wilhelm, Martin

AU - Sanhes, Laurence

AU - Lamy, Thierry

AU - de Leval, Laurence

AU - Rosenwald, Andreas

AU - Roussel, Muriel

AU - Kroschinsky, Frank

AU - Lindemann, Walter

AU - Dreger, Peter

AU - Viardot, Andreas

AU - Milpied, Noël

AU - Gisselbrecht, Christian

AU - Wulf, Gerald

AU - Gyan, Emmanuel

AU - Gaulard, Philippe

AU - Bay, Jacques Olivier

AU - Glass, Bertram

AU - Poeschel, Viola

AU - Damaj, Gandhi

AU - Sibon, David

AU - Delmer, Alain

AU - Bilger, Karin

AU - Banos, Anne

AU - Haenel, Mathias

AU - Dreyling, Martin

AU - Metzner, Bernd

AU - Keller, Ulrich

AU - Braulke, Friederike

AU - Friedrichs, Birte

AU - Nickelsen, Maike

AU - Altmann, Bettina

AU - Tournilhac, Olivier

N1 - Wilhelm: Medizinische Klinik 5, Klinikum Nuernberg, Paracelsus Medical University, Klinikum Nuernberg, Nuernberg, Germany;

PY - 2021

Y1 - 2021

KW - STEM-CELL TRANSPLANTATION

KW - VERSUS-HOST-DISEASE

KW - LYMPHOMA

KW - CRITERIA

U2 - 10.1182/blood.2020008825

DO - 10.1182/blood.2020008825

M3 - Original Article

C2 - 33512419

SN - 0006-4971

VL - 137

SP - 2646

EP - 2656

JO - BLOOD

JF - BLOOD

IS - 19

ER -

Schmitz N, Truemper L, Bouabdallah K, Ziepert M, Leclerc M, Cartron G et al. A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL. BLOOD . 2021;137(19):2646-2656. doi: 10.1182/blood.2020008825